Hematology
1924 CE, Finland — clinical documentation by Erik Adolf von Willebrand; general bleeding disorder descriptions appear in the Ebers Papyrus, c. 1550 BCE, ancient Egypt
Von Willebrand disease was a bleeding disorder that puzzled physicians for centuries before its distinct identity was formally established in the early twentieth century. Finnish physician Erik Adolf von Willebrand conducted foundational investigations in the 1920s that separated it from other known bleeding conditions. His work on a family in the Åland Islands provided the clinical and hereditary evidence that eventually bore his name.
Historical Narrative
Long before the condition received its modern designation, healers and physicians across many cultures encountered patients — often women and children — who bled unusually and persistently from minor wounds, tooth extractions, and spontaneous sources. Ancient Egyptian medical texts such as the Ebers Papyrus documented bleeding ailments in general terms, though no distinction was made between what later generations would classify as separate hemorrhagic conditions. Greco-Roman physicians, including Galen, attributed prolonged bleeding to imbalances in the four humors, particularly an excess of blood or a thinning of its constitution, and prescribed dietary restrictions, astringents, and cauterization to counteract these perceived imbalances.
During the medieval period, European physicians continued to interpret bleeding disorders through humoral theory, while Islamic scholars such as Ibn Sina, writing in the Canon of Medicine, described blood that lacked proper coagulative virtue. These practitioners recommended herbal styptics, cold compresses, and prayers, with little systematic differentiation among various bleeding tendencies.
The early modern period brought gradual anatomical and physiological advances, yet bleeding disorders remained poorly classified well into the nineteenth century. Hemophilia had been partially characterized through observations of male patients in royal and aristocratic lineages, and physicians often applied that label broadly to any patient with excessive bleeding, regardless of hereditary pattern or severity profile.
The pivotal turning point arrived in 1924 when Erik Adolf von Willebrand, a Finnish internist, began examining a five-year-old girl from Föglö in the Åland Islands who had suffered severe bleeding episodes. He subsequently extended his investigation to her extended family and observed that the bleeding pattern differed meaningfully from classical hemophilia — it affected females as prominently as males and involved bleeding from mucosal surfaces in a manner hemophilia did not typically produce. Von Willebrand published his findings in 1926 in Swedish and in 1931 in German, describing what he termed 'constitutional thrombopathia,' a hereditary condition he believed originated in a platelet or vascular defect rather than a coagulation factor deficiency.
For the following two decades, researchers debated the precise mechanism. Some European hematologists held that the disorder was primarily a vascular fragility problem, while others suspected platelet dysfunction. The Swedish physician Jorgen Jorpes contributed to clarifying the role of plasma factors in coagulation during the 1940s and 1950s, and his work on heparin and blood protein chemistry helped establish the broader framework within which bleeding disorders were re-examined.
In the 1950s, Inga Marie Nilsson and her colleagues at the University of Lund in Sweden conducted systematic investigations into the families Von Willebrand had originally studied. Their research through the 1950s and 1960s demonstrated that a specific plasma protein component was diminished or dysfunctional in affected individuals, shifting the condition's classification decisively toward a plasma protein deficiency rather than a purely platelet or vascular disorder. This work helped define von Willebrand factor as a distinct entity in coagulation science.
By the latter half of the twentieth century, the condition had been formally catalogued with multiple hereditary subtypes, and laboratory methods developed during that era allowed researchers to differentiate among them with increasing precision. The trajectory from humoral speculation to molecular characterization spanned roughly two and a half millennia.
Key Historical Figures
Historical narrative only — this page describes how Von Willebrand disease was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.